Altogether, these results showed that CREB3L4 could work as the collaborative partner of HOXB13, potentially through direct protein–protein interactions, to promote its proliferative activity in prostate-cancer-derived PC-3 cells. Here, CREB3L4 is linked to prostate cancer.